 | • レポートコード：MRC2304A199 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、233ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に1,583.38百万ドルであった世界のエピジェネティクス市場規模が2022年に1,871.23百万ドルへと拡大、更に2027年までにCAGR 18.43％で成長して4,369.83百万ドルに達すると予測しています。当書は、エピジェネティクスの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別分析（質量分析、NGS、PCR＆qPCR、超音波処理）、方法別分析（DNAメチル化、ヒストン修飾）、用途別分析（心血管疾患、発生生物学、免疫、代謝疾患、腫瘍）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの構成でまとめています。なお、当書には、Abcam PLC、Active Motif, Inc.、Bio-Rad Laboratories、Creative Biogene、Diagenode、EpiCypher、EpiGentek Group Inc.、Everon Life Sciences、F Hoffmann-La Roche Ltd.、Fios Genomics、GenomeScan、Illumina, Inc.、Merck KGaAなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のエピジェネティクス市場規模：製品別 - 酵素の市場規模 - 器具＆付属品の市場規模 - 試薬＆キットの市場規模 - サービスの市場規模 - ソフトウェアの市場規模 ・世界のエピジェネティクス市場規模：技術別 - 質量分析の市場規模 - NGSの市場規模 - PCR＆qPCRの市場規模 - 超音波処理の市場規模 ・世界のエピジェネティクス市場規模：方法別 - DNAメチル化の市場規模 - ヒストン修飾の市場規模 ・世界のエピジェネティクス市場規模：用途別 - 心血管疾患における市場規模 - 発生生物学における市場規模 - 免疫における市場規模 - 代謝疾患における市場規模 - 腫瘍における市場規模 ・世界のエピジェネティクス市場規模：地域別 - 南北アメリカのエピジェネティクス市場規模 アメリカのエピジェネティクス市場規模 カナダのエピジェネティクス市場規模 ブラジルのエピジェネティクス市場規模 ... - アジア太平洋のエピジェネティクス市場規模 日本のエピジェネティクス市場規模 中国のエピジェネティクス市場規模 インドのエピジェネティクス市場規模 韓国のエピジェネティクス市場規模 台湾のエピジェネティクス市場規模 ... - ヨーロッパ/中東/アフリカのエピジェネティクス市場規模 イギリスのエピジェネティクス市場規模 ドイツのエピジェネティクス市場規模 フランスのエピジェネティクス市場規模 ロシアのエピジェネティクス市場規模 ... - その他地域のエピジェネティクス市場規模 ・競争状況 ・企業情報 |
The Global Epigenetics Market size was estimated at USD 1,583.38 million in 2021 and expected to reach USD 1,871.23 million in 2022, and is projected to grow at a CAGR 18.43% to reach USD 4,369.83 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Epigenetics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Enzymes, Instruments & Accessories, Reagents & Kits, Service, and Software. The Enzymes is further studied across DNA-modifying Enzymes and Protein-modifying Enzymes. The Reagents & Kits is further studied across 5-hmC and 5-mC Analysis Kits, Antibodies, Bisulfite Conversion Kits, ChiP-seq Kits, Histones, and Whole Genome Amplification Kits.
Based on Technique, the market was studied across Mass Spectrometry, NGS, PCR & qPCR, and Sonication.
Based on Methods, the market was studied across DNA Methylation and Histone Modifications.
Based on Application, the market was studied across Cardiovascular Diseases, Developmental Biology, Immunology, Metabolic Diseases, and Oncology.
Based on End User, the market was studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Epigenetics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Epigenetics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Epigenetics Market, including Abcam PLC, Active Motif, Inc., Bio-Rad Laboratories, Creative Biogene, Diagenode, EpiCypher, EpiGentek Group Inc., Everon Life Sciences, F Hoffmann-La Roche Ltd., Fios Genomics, GenomeScan, Illumina, Inc., Merck KGaA, New England Biolabs, PacBio, PerkinElmer, Promega Corporation, Qiagen, Thermo Fisher Scientific, and Zymo Research Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Epigenetics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Epigenetics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Epigenetics Market?
4. What is the competitive strategic window for opportunities in the Global Epigenetics Market?
5. What are the technology trends and regulatory frameworks in the Global Epigenetics Market?
6. What is the market share of the leading vendors in the Global Epigenetics Market?
7. What modes and strategic moves are considered suitable for entering the Global Epigenetics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant growth in prevalence of chronic and genetic disorders worldwide
5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
5.1.1.3. Rising investments in pharmaceuticals and biopharmaceuticals manufacturing
5.1.2. Restraints
5.1.2.1. Limited application of epigenetics
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for advancement of epigenetics
5.1.3.2. Emergence of novel infectious disorders worldwide
5.1.4. Challenges
5.1.4.1. Scarcity of skilled professionals for research and development activities
5.2. Cumulative Impact of COVID-19
6. Epigenetics Market, by Product
6.1. Introduction
6.2. Enzymes
6.3.1. DNA-modifying Enzymes
6.3.2. Protein-modifying Enzymes
6.3. Instruments & Accessories
6.4. Reagents & Kits
6.5.1. 5-hmC and 5-mC Analysis Kits
6.5.2. Antibodies
6.5.3. Bisulfite Conversion Kits
6.5.4. ChiP-seq Kits
6.5.5. Histones
6.5.6. Whole Genome Amplification Kits
6.5. Service
6.6. Software
7. Epigenetics Market, by Technique
7.1. Introduction
7.2. Mass Spectrometry
7.3. NGS
7.4. PCR & qPCR
7.5. Sonication
8. Epigenetics Market, by Methods
8.1. Introduction
8.2. DNA Methylation
8.3. Histone Modifications
9. Epigenetics Market, by Application
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Developmental Biology
9.4. Immunology
9.5. Metabolic Diseases
9.6. Oncology
10. Epigenetics Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Epigenetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Epigenetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Epigenetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abcam PLC
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Active Motif, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Bio-Rad Laboratories
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Creative Biogene
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Diagenode
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. EpiCypher
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. EpiGentek Group Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Everon Life Sciences
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. F Hoffmann-La Roche Ltd.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Fios Genomics
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. GenomeScan
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Illumina, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Merck KGaA
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. New England Biolabs
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. PacBio
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. PerkinElmer
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Promega Corporation
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Qiagen
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Thermo Fisher Scientific
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Zymo Research Corporation
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing